ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "antigen RA"

  • Abstract Number: 2900 • ACR/ARHP Annual Meeting 2018

    Impaired TCR Signaling Paves the Way for Cytokine Hyper-Responsiveness in Arthritogenic T Cells

    Judith Ashouri1, Lih-Yun Hsu1, Dmitry Rychkov2, Marina Sirota2, Lisa Lattanza3, Eric Hansen3, Julie Zikherman1 and Arthur Weiss1, 1Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco, CA, 2Pediatrics, Institute for Computational Health Sciences, University of California, San Francisco, San Francisco, CA, 3Orthopedic Surgery, University of California, San Francisco, San Francisco, CA

    Background/Purpose: The inability to identify relevant arthritogenic CD4 T cells in patients and in murine disease models has limited our understanding of disease initiating events…
  • Abstract Number: 834 • ACR/ARHP Annual Meeting 2017

    Citrulline-Polyspecific B Cell Antigen Receptors Arising from Somatic Hypermutation within Clades Demonstrate Pathogenicity in Rheumatoid Arthritis

    Philip J. Titcombe1,2, Gustaf Wigerblad3, Natalie Sippl3, Na Zhang1, Anna K. Shmagel4, Peter Sahlström5, Yue Jack Zhang1, Laura Barsness Motschenbacher1, Yogita Ghodke-Puranik6, Monika Hansson7, Lena Israelsson5, Timothy B. Niewold8, Lars Klareskog9, Camilla Svensson10, Khaled Amara7, Vivianne Malmström11 and Daniel L. Mueller1, 1Medicine/Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis, MN, 2Rheumatology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, 3Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 4Rheumatic & Autoimmune Diseases, University of Minnesota Medical School, Minneapolis, MN, 5Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 6Colton Center for Autoimmunity, New York University, New York, NY, 7Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 8Rheumatology and Immunology, Mayo Clinic, Rochester, MN, 9Rheumatology unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 10Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden, 11Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Citrulline–modified proteins arising from the post-translational modification of arginine residues are recognized as primary rheumatoid arthritis (RA) autoantigen targets based on the strong association…
  • Abstract Number: 951 • ACR/ARHP Annual Meeting 2017

    Cross Sectional Analysis of Citrullinated-Synovial Antigen-Specific CD4+ T Cells in an RA Cohort Demonstrates Antigen Based Differences in T Cell Frequency, Phenotype and the Influence of Immunotherapy

    Cliff Rims1, Sylvia Posso1, Bernard Ng2, Jeffrey Carlin3, Eddie James4 and Jane H. Buckner4, 1Translational Research, Benaroya Research Institute at Virginia Mason, Seattle, WA, 2Rheumatology, VA Puget Sound Healthcare System, Seattle, WA, 3Rheumatology, Virginia Mason Medical Center, Seattle, WA, 4Benaroya Research Institute at Virginia Mason, Seattle, WA

    Background/Purpose: The presence of ACPA in RA indicates that an immune response directed toward citrullinated synovial antigens participates in disease development or persistence. Research from…
  • Abstract Number: 3022 • ACR/ARHP Annual Meeting 2016

    Autoantibodies to Peptidylarginine Deiminase 2 Protect Against Radiographic Progression in Patients with Rheumatoid Arthritis

    Erika Darrah1, Jon T. Giles2, Ryan Davis1, Pooja Naik1, Maximilian Konig1 and Felipe Andrade1, 1Department of Medicine, Division of Rheumatology, The Johns Hopkins University, Division of Rheumatology, Baltimore, MD, 2Columbia University, College of Physicians and Surgeons, Division of Rheumatology, New York, NY

    Background/Purpose:  The mechanisms that drive clinical heterogeneity and outcomes in patients with rheumatoid arthritis (RA) are poorly understood, but precise biomarkers may identify clinically unique…
  • Abstract Number: 1946 • ACR/ARHP Annual Meeting 2015

    A Novel HLA-DRB1*10:01 Restricted T Cell Epitope from Citrullinated Type II Collagen Relevant for Rheumatoid Arthritis

    Karine Chemin1, Sabrina Pollastro2, Eddie James3, Changrong Ge4, Inka Albrecht5, Jessica Herrath6, Christina Gerstner7, Thais Rizzi2, Karolina Tandre8, Lars Rönnblom8, Anca I Catrina9, Rikard Holmdahl10, L. Klareskog11, Niek De Vries12 and Vivianne Malmström11, 1Medicine, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 2Department of Clinical Immunology and Rheumatology, Amsterdam, Netherlands, 3Benaroya Research Institute at Virginia Mason, Seattle, WA, 4Department of Medical Biochemistry and Biophysics, Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden, 5Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 6Department of Medicine,, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 7Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Solna, Stockholm, Sweden, 8Section of Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 9Unit of Rheumatology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 10Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, 11Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 12Dept. of Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: Antibodies against citrullinated collagen type II (Cit-CII) are common in sera and synovial fluids of Rheumatoid Arthritis (RA) patients, whereas the known CII T-cell…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology